Yang Yin Fu Zheng Therapy in HBV Associated Hepatocellular Carcinoma
NCT02927626
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
COMPLETED
Status
132
Enrollment
OTHER
Sponsor class
Conditions
Hepatocellular Carcinoma
Interventions
DRUG:
Yang Yin Fu Zheng therapy
DRUG:
Routine medical care
Sponsor
Beijing Ditan Hospital